Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer
Clinical trial NCT07080216 · RECRUITING
Trial details
- NCT number
- NCT07080216
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-23
- Primary completion
- 2027-08-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.